Surgery Partners, Inc. (NASDAQ: SGRY) reported Q1 EPS of ($0.42), $0.14 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $418.8 million versus the consensus estimate of $423.61 million.

Guidance

The Company continues to project that it will be able to grow revenues at a low single-digit percentage rate in 2019; when the 2018 baseline is adjusted for divested revenues, 2019 revenue growth is projected to be high single digits. The Company also continues to project that it will be able to grow Adjusted EBITDA at a double-digit percentage rate in 2019, which is expected to be weighted more towards the back half of the year. The Company’s outlook does not incorporate the impact of unidentified acquisitions and also does not include the impact of de novo activity.

For earnings history and earnings-related data on Surgery Partners, Inc. (SGRY) click here.